- Generic name
- Empagliflozin + Metformin Hydrochloride
- Strength
- 5 mg + 850 mg
- Dosage form
- Tablet
- Manufactured by
- Opsonin Pharma Limited
Empadus M 5/850 Tablet
About Empadus M 5/850 Tablet
Empadus M 5/850 5 mg + 850 mg is a tablet product of Opsonin Pharma Limited that contains Empagliflozin + Metformin Hydrochloride. Doctors may prescribe it when metformin alone at the highest tolerated amount does not control blood sugar well enough.
There are 25 brands of Empagliflozin + Metformin Hydrochloride listed in Bangladesh. The lowest listed price is Ajardy M 5 mg+500 mg Tablet at ৳ 15.00 per unit.
What is Empadus M 5/850 Tablet?
The tablet Empadus M 5/850 contains Empagliflozin + Metformin Hydrochloride and is made by Opsonin Pharma Limited. Empagliflozin works on the kidneys, while metformin works mainly on the liver and how the body handles sugar. Together they help control blood glucose when diet and exercise alone are not enough. The doctor decides the dose and course.
Uses of Empadus M 5/850
Doctors may prescribe it when metformin alone at the highest tolerated amount does not control blood sugar well enough. It may also be used together with other diabetes medicines when metformin and those medicines have not given sufficient control. Only a doctor can decide if this combination is right for a person; ask your doctor about your own treatment plan. Ask your doctor whether it is right for your condition.
How to use Empadus M 5/850
Swallow the extended-release tablet whole with water and do not crush or chew it unless your doctor says otherwise. Empadus M 5/850 is taken by mouth. Shake the bottle well before each use. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Empadus M 5/850
The most common ones linked to empagliflozin are urinary tract infections and genital fungal infections. Metformin commonly causes diarrhoea, nausea or vomiting, wind, stomach discomfort, indigestion, tiredness and headache. Like other medicines, Empadus M 5/850 can cause side effects. Tell your doctor if any side effect bothers you or does not settle. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It is not recommended while breastfeeding, and women should tell their doctor if they are pregnant or planning pregnancy because of possible risk to the baby. It should be avoided in people allergic to either ingredient, in severe kidney failure, in certain conditions that raise acid levels in the body, or with heavy alcohol use, liver problems and some heart or breathing conditions; your doctor will check for these. Empadus M 5/850 is not suitable for everyone. Keep out of reach of children.
Frequently asked questions
What is Empadus M 5/850 used for?
Doctors may prescribe it when metformin alone at the highest tolerated amount does not control blood sugar well enough. It may also be used together with other diabetes medicines when metformin and those medicines have not given sufficient control.
How should I take Empadus M 5/850?
Swallow the extended-release tablet whole with water and do not crush or chew it unless your doctor says otherwise. Empadus M 5/850 is taken by mouth.
What are the side effects of Empadus M 5/850?
The most common ones linked to empagliflozin are urinary tract infections and genital fungal infections. Metformin commonly causes diarrhoea, nausea or vomiting, wind, stomach discomfort, indigestion, tiredness and headache.
Can I use Empadus M 5/850 in pregnancy or while breastfeeding?
It is not recommended while breastfeeding, and women should tell their doctor if they are pregnant or planning pregnancy because of possible risk to the baby. It should be avoided in people allergic to either ingredient, in severe kidney failure, in certain conditions that raise acid levels in the body, or with heavy alcohol use, liver problems and some heart or breathing conditions; your doctor will check for these.
Indications
- In patients insufficiently controlled on their maximally tolerated dose of Metformin alone
- In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with Metformin and these medicinal products ... Read more
- In patients insufficiently controlled on their maximally tolerated dose of Metformin alone
- In combination with other medicinal products for the treatment of diabetes, in patients insufficiently controlled with Metformin and these medicinal products
- In patients already being treated with the combination of Empagliflozin and Metformin as separate tablets.
Pharmacology
Metformin Hydrochloride is a biguanide type oral antihyperglycemic drug, used in the management of type 2 diabetes. It lowers both basal and postprandial plasma glucose. It does not produce hypoglycemia. Metformin Hydrochloride decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by an increase in peripheral glucose uptake and utilization.
Dosage & Administration
Recommended individualized starting dose:
- In patients on Metformin Hydrochloride, switch to this combination containing Empagliflozin 5 mg with a similar total daily dose of Metformin Hydrochloride.
- In patients on Empagliflozin, switch to this combination containing Metformin Hydrochloride 500 mg with a similar total daily dose of Empagliflozin.
- In patients already treated with Empagliflozin and Metformin Hydrochloride separately switch to this combination containing the same total daily doses of each component.
- In patients with volume depletion not previously treated with Empagliflozin, correct this condition before initiating this combination.
Pediatric patients under 18 years of age: Safety and effectiveness in pediatric patients under 18 years of age have not been established.
Interaction
Insulin or Insulin Secretagogues: Co-administration of Empagliflozin with insulin or insulin secretagogues increases the risk for hypoglycemia.
Positive Urine Glucose Test: Monitoring glycemic control with urine glucose tests is not recommended in patients taking SGLT2 inhibitors. Use alternative methods to monitor glycemic control.
Drugs that Reduce Metformin Clearance: Drugs that reduce Metformin clearance (such as ranolazine, vandetanib, dolutegravir, and cimetidine) may increase the accumulation of Metformin.
Carbonic Anhydrase Inhibitors: Carbonic anhydrase inhibitors may increase risk of lactic acidosis.
Drugs Affecting Glycemic Control: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid produce hoperglycemia. When such drugs are administered to a patient receiving Empagliflozin and Metformin combination, the patient should be closely observed to maintain adequate glycemic control. When such drugs are withdrawn from a patient receiving Empagliflozin and Metformin combination, the patient should be observed closely for hypoglycemia.
Alcohol: Alcohol can potentiate the effect of Metformin on lactate metabolism. Warn patients against excessive alcohol intake.
Contraindications
- Hypersensitivity to Empagliflozin and Metformin
- Any type of acute metabolic acidosis (such as lactic acidosis, diabetic ketoacidosis)
- Diabetic pre-coma
- Severe renal failure (GFR <30 ml/min)
- Acute conditions with the potential to alter renal function such as: dehydration, severe infection, shock
- Disease which may cause tissue hypoxia (especially acute disease, or worsening of chronic disease) such as: decompensated heart failure, respiratory failure, recent myocardial infarction, shock
- Hepatic impairment, acute alcohol intoxication, alcoholism
Side Effects
- Very common: Hypoglycemia (when used with sulphonylurea or insulin), Gastrointestinal symptoms
- Common: Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection. Urinary tract infection (including pyelonephritis and urosepsis), thirst, taste disturbance, pruritus (generalised), rash, Increased urination, serum lipids increased
- Uncommon: Volume depletion, urticaria, dysuria, blood creatinine increased/Glomerular filtration rate decreased, Haematocrit increased
- Rare: Diabetic ketoacidosis.
Pregnancy & Lactation
Precautions & Warnings
Hypotension: Before initiating this combination assess and correct volume status in patients with renal impairment, the elderly, in patients with low systolic blood pressure, and in patients on diuretics. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected.
Ketoacidosis: Before initiating this combination assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. If suspected, discontinue this combination, evaluate and treat promptly.
Acute kidney injury & impairment in renal function: Consider temporarily discontinuing this combination in settings of reduced oral intake or fluid losses. If acute kidney injury occurs, discontinue this combination promptly and institute treatment.
Urosepsis, Pyelonephritis, Fournier’s gangrene & Genital mycotic infections: Treatment with SGLT2 inhibitors increases the risk for urinary tract infections. Evaluate patients for signs and symptoms of urinary tract infections and treat promptly, if indicated.
Hypoglycemia: Consider lowering the dose of insulin secretagogue or insulin to reduce the risk of hypoglycemia when initiating this combination.
Vitamin B12 Deficiency: Metformin Hydrochloride may lower vitamin B12 levels. Monitor hematologic parameters annually.
Increased LDL-C: Monitor and treat as appropriate.
Macrovascular Outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with this combination.
Overdose Effects
Storage Conditions
Alternative brands of Empagliflozin + Metformin Hydrochloride
Other brands with the same generic name, cheapest first.
Ajardy M Tablet
5 mg+500 mg
Empagliflozin + Metformin Hydrochloride
Ziska Pharmaceuticals Ltd.
৳ 14.7 ৳ 15.00 2% off per unit
Diampa-M Tablet Tablet
5 mg + 500 mg
Empagliflozin + Metformin Hydrochloride
Renata PLC.
৳ 17.64 ৳ 18 2% off per unit
Adempa-M Tablet
5 mg+500 mg
Empagliflozin + Metformin Hydrochloride
UniMed UniHealth Pharmaceuticals Ltd.
৳ 19.6 ৳ 20.00 2% off per unit
empazin M 12.5/500 Tablet
12.5 mg + 500 mg
Empagliflozin + Metformin Hydrochloride
Delta Pharma Limited
৳ 19.6 ৳ 20 2% off per unit
Ardance-M Tablet
5 mg+500 mg
Empagliflozin + Metformin Hydrochloride
Pharmacil Limited
৳ 22.54 ৳ 23.00 2% off per unit
Glifo-M 12.5/500 Tablet
12.5 mg + 500 mg
Empagliflozin + Metformin Hydrochloride
The ACME Laboratories Ltd.
৳ 29.4 ৳ 30 2% off per unit
Glifo-M XR 10/1000 Xr Tablet
10 mg + 1000 mg
Empagliflozin + Metformin Hydrochloride
The ACME Laboratories Ltd.
৳ 29.4 ৳ 30 2% off per unit
COPORT M 5/500 Tablet
5 mg + 500 mg
Empagliflozin + Metformin Hydrochloride
Advanced Chemical Industries PLC
Price not listed
Coport M XR 10/1000 ER Xr Tablet
10 mg + 1000 mg
Empagliflozin + Metformin Hydrochloride
Advanced Chemical Industries PLC
Price not listed
Coport M XR 25/1000 Xr Tablet
25 mg + 1000 mg
Empagliflozin + Metformin Hydrochloride
Advanced Chemical Industries PLC
Price not listed
COPORT M XR 5/1000 ER Xr Tablet
5 mg + 1000 mg
Empagliflozin + Metformin Hydrochloride
Advanced Chemical Industries PLC
Price not listed
Empadus M 12.5/1000 Tablet
12.5 mg + 1000 mg
Empagliflozin + Metformin Hydrochloride
Opsonin Pharma Limited
Price not listed
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.